Pharmaceutical Companies and CROs

Definiens’ technology is massively scalable, capable of handling large studies in the context of drug, biomarker and diagnostics development. This greatly increases the speed and accuracy of image analysis, in turn, helping to lower attrition rates and to reduce time-to-market for new medicines.

Definiens’ image analysis solutions are used throughout discovery, toxicological studies and clinical trials to identify valid targets and to prevent poor compounds going forward.

Definiens’ technology works with all biomedical image formats, making it the ideal tool to harmonize image analysis across all stages of research.

How Definiens helps in Research and Development